Two-piece Empty Hard Capsule Market Size To Expand at a Notable CAGR Of 7.32% During 2018 - 2023

Pune, India, March, 2019/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Two-piece Empty Hard Capsule Market

Overview:

Two-piece empty hard capsules have provided new avenues to address the increasing personalization in medicine development. With these specifically designed capsules which can be easily opened by hand, sprinkle drug delivery systems can achieve their full potential.

With the regulatory and technological advances, that leverage the benefits of large-scale multiparticulate manufacturing combined with the high degree of flexibility for personalization offered by globally available standard industrial capsule filling the market for two-piece empty hard capsules is proliferating.

Acknowledging the tremendous market prominence that these capsules are garnering, and a colossal growth that its market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global two-piece empty hard capsule market will demonstrate a spectacular growth by 2023, registering a CAGR of 7.32% during the assessment period (2022-2030).

Additional factors that are supporting the market growth include the increasing personalization of therapies and the regulations in the developed regions of Europe and North America that request direct patient involvement in drug formulation in order to better evaluate risk-to-benefit for patients by capturing their personal experiences with specific therapies. This, as a result, increases the importance of the mode of administration and the product usability making them major endpoints for the benefit-risk evaluation and product approval.

Moreover, factors such as the increasing inclination of pharmaceutical firms towards the production of two-piece capsule format to cater the consumer demand alongside the substantial investments made in R&D for innovations to accelerate the production flow are impacting the growth of the market, positively.

On other hand, factors such as the high manufacturing cost and complexity of production, along with the unclear regulatory policies in many countries are expected to pose major constraints for the growth of the global two-piece empty hard capsule market. Nevertheless, technological advancements coupled with the growing number of pharma companies that can manufacture two-piece empty hard capsule on a high production rate is expected to support the growth of the market by bringing the production cost down.Two-piece Empty Hard Capsule Market – Segmentation

For enhanced understanding, the market has been segmented into three key dynamics: -

By Raw Material: Gelatin, Hydroxypropyl Methylcellulose (HPMC), Starch, and Pullulan among others.

By End-use: Pharmaceuticals, and Health & Nutrition among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

Two-piece Empty Hard Capsule Market –

Regional Analysis

The North American region, heading with the burgeoning precision medicines market, dominates the global two-piece empty hard capsule market. Being a well-developed region with the highest GDP, worldwide, North America has an edge over other regions in terms of every aspect including technology and healthcare. Factors such as the vast technological advancements in medical technology that are moving the pharmaceutical industry from its traditional manufacturing approach toward more customization up to the point of manufacturing are supporting the growth of the market.

Also, the vast patient pool suffering from chronic diseases such as diabetes and cancer and the presence of geriatric populations in the region drives the growth of the regional market. Undoubtedly, the high economic growth is a key driving force behind the growth of the regional market that allows wide access to the quality of life for the people. Owing to the augmenting demand for the two-piece empty hard capsule for precision medicines, the region will create a larger revenue pocket in the global market by 2030.

The two-piece empty hard capsule market in the European region stands the second-largest position, globally.  The resurging economy is playing a key role in the development of the market, allowing increasing access to healthcare in the region. Germany, heading with its overall, rapidly developing technology, contributes to the growth of the regional market hugely. Furthermore, the U.K. and France with the increasing investment in personalized medicines and pharmaceutical industry drive the regional two-piece empty hard capsule market at a large scale.

The Asia Pacific two-piece market empty hard capsule market is emerging as a profitable market, globally. Improving economic conditions in the region is a key driving force pushing up the two-piece empty hard capsule market. Besides, the huge technological advancements, the burgeoning pharmaceutical industry, and the rising demand for two-piece empty hard capsules foster the growth of the regional market.

Furthermore, factors such as the huge patient population that dictates the demand for quality healthcare in the rapidly developing countries such as China, Japan, South Korea, and India is expected to lead the market growth in the APAC region.

Two-piece Empty Hard Capsule Market – Competitive Analysis

Highly competitive by nature, two-piece empty hard capsule market appears to be fragmented yet consolidated with the limited number of well-established players operating in the market. These well-established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage in this market. Top players are substantially investing in R&D and clinical trials to accelerate product development and innovations and to cut down production costs.

Major Players:

Key players leading the global two-piece empty hard capsules market include ACG Worldwide (India), Suheung Co., Ltd. (South Korea), Hunan ER-KANG Pharmaceutical Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd. (China), CapsCanada Corporation (Canada), Capsugel (U.S.), and Qualicaps, Inc. (U.S.) among others.

Industry/Innovation/ Related News:

February 07, 2019 ---- A team of researchers at M.I.T., Harvard (the US), one of the largest biomedical engineering and physician-scientist training programs and Novo Nordisk A/S (Denmark), a multinational pharmaceutical company announced the development of a tiny robotic capsule – Soma - that injects insulin once it lands in the stomach.

Soma works in rats and pigs, and the researchers hope to start testing Soma in humans in three years. This capsule could be a viable solution to the injection problem like insulin or monoclonal antibodies used to treat cancers and other diseases without injections.

Read More About This Report: two-piece empty hard capsules market size